Jeena Sikho Lifecare (NSE:JSLL) Accounts Receivable: ₹699 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:JSLL Jeena Sikho Lifecare Ltd NSE:JSLL
92 GF Score
Price ₹567.65
GF Value ₹779.21
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Jeena Sikho Lifecare Accounts Receivable?

Jeena Sikho Lifecare NSE:JSLL -2.21% 92 Accounts Receivable is ₹699 Mil as of Mar. 2026. GuruFocus rates NSE:JSLL with a GF Score™ of 92/100 and a GF Value™ of ₹779.21 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Jeena Sikho Lifecare's accounts receivables for the quarter that ended in Mar. 2026 was ₹699 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Jeena Sikho Lifecare's Days Sales Outstanding for the quarter that ended in Mar. 2026 was 29.60.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Jeena Sikho Lifecare's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was ₹6.60.

Jeena Sikho Lifecare Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Jeena Sikho Lifecare's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=699.291/2155.532*91
=29.60

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Jeena Sikho Lifecare's accounts receivable are only considered to be worth 75% of book value:

Jeena Sikho Lifecare's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(2266.382+0.75 * 699.291+0.5 * 202.182-2072.91
-0--1.282)/124.301
=6.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Jeena Sikho Lifecare Accounts Receivable Related Terms

Jeena Sikho Lifecare Accounts Receivable Historical Data

* Premium members only.

The historical data trend for Jeena Sikho Lifecare's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jeena Sikho Lifecare Accounts Receivable Chart

Jeena Sikho Lifecare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Receivable
Get a 7-Day Free Trial 90.43 220.72 411.85 976.30 699.29

Jeena Sikho Lifecare Quarterly Data
Mar19 Mar20 Mar21 Sep21 Mar22 Mar23 Mar24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 976.30 0.00 928.30 0.00 699.29
NSE:JSLL
92GF Score
Jeena Sikho Lifecare Ltd NSE:JSLL
Accounts Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jeena Sikho Lifecare Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Frequently Asked Questions Learn more about Accounts Receivable →
What does a Accounts Receivable of ₹699 Mil mean?
Jeena Sikho Lifecare (NSE:JSLL) has a Accounts Receivable of ₹699 Mil as of Mar. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Jeena Sikho Lifecare and its competitors.
Is Jeena Sikho Lifecare's Accounts Receivable too high?
Jeena Sikho Lifecare's current Accounts Receivable is ₹699 Mil. Overall, Jeena Sikho Lifecare has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's Accounts Receivable compare to HCA and THC?
Jeena Sikho Lifecare's Accounts Receivable of ₹699 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Healthcare Providers & Services company?
A good Accounts Receivable depends on the Healthcare Providers & Services industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Jeena Sikho Lifecare and its competitors. Jeena Sikho Lifecare's current Accounts Receivable is ₹699 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹779.21, compared to a current price of ₹567.65 — trading 27.2% below its estimated fair value. The current Accounts Receivable is ₹699 Mil. Jeena Sikho Lifecare's overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current Accounts Receivable is ₹699 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?

Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued. The current stock price of ₹567.65 is trading 27.2% below its estimated GF Value™ of ₹779.21. GuruFocus considers Jeena Sikho Lifecare to be Modestly Undervalued.

Key valuation signals for NSE:JSLL:

  • Accounts Receivable: ₹699 Mil
  • GF Value™: ₹779.21 vs. price of ₹567.65 (27.2% below fair value)
  • GF Score™: 92/100 with 3 warning signs

No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jeena Sikho Lifecare Business Description

Other Exchanges 544476:India
Address Kalgidhar Enclave, SCO 11 First Floor, Mohali, Zirakpur, PB, IND, 140604
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
92GF Score

Get the complete analysis for NSE:JSLL

Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹567.65
Price
₹779.21
GF Value